Group Leader, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi
Project Overview
The aim of this study is to deliver novel peptidomimetic inhibitors targeting Mpro and PLpro with therapeutic potential, validated in vitro and in vivo using recent animal models for SARS-CoV-2.
Group Leader, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi
Accessibility Controls